Creation of a Novel Child Simulator and Curriculum to Optimize Administration of Seizure Rescue Medication

Coral M Stredny1, Theodore Sheehan, Justice Clark

  • 1From the Division of Epilepsy and Clinical Neurophysiology, Department of Neurology (C.M.S., T.S., J.C., C.T., C.G., T.K., C.C., T.L.), Boston Children's Hospital, Boston, MA; Immersive Design Systems (B.O'C., K.G., G.L., S.W., P.H.W.), Boston Children's Hospital, Boston, MA; Clinical Research Center (P.W.F.), Boston Children's Hospital, Boston, MA; Department of Anesthesiology, Critical Care and Pain Medicine (P.H.W.), Boston Children's Hospital, MA; and Harvard Medical School (C.M.S., P.H.W., T.L.), Boston, MA.

Insights

Caregivers need training for pediatric seizure rescue medications. A realistic rectal diazepam simulator and scoring system improved medication administration accuracy and speed in simulations.

Area of Science:

  • Pediatric Emergency Medicine
  • Medical Simulation Training

Background:

  • Pediatric convulsive status epilepticus often begins pre-hospital, yet many patients remain untreated.
  • Caregiver training in administering prehospital seizure rescue medications is insufficient.

Purpose of the Study:

  • To develop and evaluate a novel simulation model for training rectal diazepam administration.
  • To assess the effectiveness of a standardized scoring system for this training.

Main Methods:

  • A proof-of-principle mannequin and simulation were developed for rectal diazepam administration.
  • A scoring paradigm was created to standardize and assess the educational process.
  • Healthcare providers and parents/guardians participated in the simulation study.

Main Results:

  • The rectal diazepam simulator demonstrated high realism (≥4/5 Likert scale).
  • Simulation training reduced treatment time (-12.3 seconds) and improved medication delivery accuracy (-4.2 points).
  • The scoring technique showed good interrater reliability (≥86%) and feasibility.

Conclusions:

  • A novel child simulator and scoring system effectively train caregivers in using seizure rescue medications.
  • This innovative approach enhances preparedness for pediatric emergencies.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
234
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
479
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
361
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K